The Worldwide Vascular Patches Industry is Projected to Reach $517 Million by 2027 - Rising Incidence of CVD is Driving Growth - ResearchAndMarkets.com

12 Dec 2022
www.businesswire.com
AHA
DUBLIN--(BUSINESS WIRE)--The "Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
'Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027'
The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period.
The biologic vascular patches held the largest share of the vascular patches market, by material
Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.
The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application
Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.
Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period
Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.
The Asia Pacific market is expected to grow at the highest CAGR during the forecast period
The global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of the target population and improved healthcare infrastructures in Southeast Asian countries.
Market Dynamics
Rising Incidence of CVD
Growing Geriatric Population and Subsequent Prevalence of Vascular Diseases
Rising Number of Cardiovascular Surgeries Worldwide
Availability of Reimbursement for Vascular Procedures
Growing Adoption of Biological Patches
Restraints
High Procedural Cost of Vascular Surgeries and Associated Products
Product Failures and Recalls
Opportunities
Emerging Economies
Growth in the Number of Hospitals & Surgical Centers
Challenges
Lack of Skilled Professionals
Companies Mentioned
B. Braun
Becton, Dickinson and Company
Labcor Laboratorios Ltda.
Synkromax Biotech Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/7s1761
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.